The zebrafish as a tool in leukemia research

Leukemia Research

Volumn 36, Issue 9, 2012, Pages 1082-1088

  Teittinen, Kaisa J ^a   Grönroos, Toni ^a   Parikka, Mataleena ^b,c   Rämet, Mika ^b,c,d   Lohi, Olli ^a,d  

^a UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^b Institute of Biomedical Technology   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Leukemia; Model; Transgenic; Xenotransplantation; Zebrafish

Indexed keywords

AFIMOXIFENE; CYCLOPHOSPHAMIDE; INTERCELLULAR ADHESION MOLECULE 1; JANUS KINASE 2; MYC PROTEIN; NUCLEOPORIN 98; PREDNISOLONE; PROTEIN BCL 2; PROTEIN KINASE B; TRANSCRIPTION FACTOR RUNX1; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; AML1 ETO GENE; CANCER MODEL; CANCER PROGNOSIS; CANCER RESEARCH; CANCER RISK; DRUG RESEARCH; DRUG SCREENING; GENE; GENETIC ANALYSIS; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH THROUGHPUT SCREENING; HUMAN; LEUKEMOGENESIS; MOLECULARLY TARGETED THERAPY; NONHUMAN; NUP98 HOXA9 GENE; PRIORITY JOURNAL; REVIEW; TEL AML1 GENE; TEL JAK2 GENE; TRANSGENE; TRANSGENIC ANIMAL; TREATMENT OUTCOME; TUMOR XENOGRAFT; ZEBRA FISH;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LEUKEMIA; RESEARCH; XENOGRAFT MODEL ANTITUMOR ASSAYS; ZEBRAFISH;

EID: 84863998539     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2012.06.001     Document Type: Review

References (71)

1. Zelent A., Greaves M., Enver T. Role of the TEL-AML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia. Oncogene 2004, 23(24):4275-4283.
2. Teitell M.A., Pandolfi P.P. Molecular genetics of acute lymphoblastic leukemia. Annu Rev Pathol 2009, 4:175-198.
3. Mori H., Colman S.M., Xiao Z., Ford A.M., Healy L.E., Donaldson C., et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci USA 2002, 99(12):8242-8247.
4. Fischer M., Schwieger M., Horn S., Niebuhr B., Ford A., Roscher S., et al. Defining the oncogenic function of the TEL/AML1 (ETV6/RUNX1) fusion protein in a mouse model. Oncogene 2005, 24(51):7579-7591.
5. Niebuhr B., Fischer M., Tager M., Cammenga J., Stocking C. Gatekeeper function of the RUNX1 transcription factor in acute leukemia. Blood Cells Mol Dis 2008, 40(2):211-218.
6. Lessman C.A. The developing zebrafish (Danio rerio): a vertebrate model for high-throughput screening of chemical libraries. Birth Defects Res C Embryo Today 2011, 93(3):268-280.
7. Peal D.S., Peterson R.T., Milan D. Small molecule screening in zebrafish. J Cardiovasc Transl Res 2010, 3(5):454-460.
8. Amsterdam A., Hopkins N. Mutagenesis strategies in zebrafish for identifying genes involved in development and disease. Trends Genet 2006, 22(9):473-478.
9. Bill B.R., Petzold A.M., Clark K.J., Schimmenti L.A., Ekker S.C. A primer for morpholino use in zebrafish. Zebrafish 2009, 6(1):69-77.
10. McCammon J.M., Doyon Y., Amacher S.L. Inducing high rates of targeted mutagenesis in zebrafish using zinc finger nucleases (ZFNs). Methods Mol Biol 2011, 770:505-527.
11. Jing L., Zon L.I. Zebrafish as a model for normal and malignant hematopoiesis. Dis Model Mech 2011, 4(4):433-438.
12. Carradice D., Lieschke G.J. Zebrafish in hematology: sushi or science?. Blood 2008, 111(7):3331-3342.
13. Ellett F., Lieschke G.J. Zebrafish as a model for vertebrate hematopoiesis. Curr Opin Pharmacol 2010, 10(5):563-570.
14. Paik E.J., Zon L.I. Hematopoietic development in the zebrafish. Int J Dev Biol 2010, 54(6-7):1127-1137.
15. Donovan A., Brownlie A., Zhou Y., Shepard J., Pratt S.J., Moynihan J., et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 2000, 403(6771):776-781.
16. Bai X., Kim J., Yang Z., Jurynec M.J., Akie T.E., Lee J., et al. TIF1gamma controls erythroid cell fate by regulating transcription elongation. Cell 2010, 142(1):133-143.
17. Wingert R.A., Galloway J.L., Barut B., Foott H., Fraenkel P., Axe J.L., et al. Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis. Nature 2005, 436(7053):1035-1039.
18. Shaw G.C., Cope J.J., Li L., Corson K., Hersey C., Ackermann G.E., et al. Mitoferrin is essential for erythroid iron assimilation. Nature 2006, 440(7080):96-100.
19. Lieschke G.J., Trede N.S. Fish immunology. Curr Biol 2009, 19(16):R678-R682.
20. Renshaw S.A., Trede N.S. A model 450millionyears in the making: zebrafish and vertebrate immunity. Dis Model Mech 2012, 5(1):38-47.
21. Langenau D.M., Traver D., Ferrando A.A., Kutok J.L., Aster J.C., Kanki J.P., et al. Myc-induced T cell leukemia in transgenic zebrafish. Science 2003, 299(5608):887-890.
22. Langenau D.M., Feng H., Berghmans S., Kanki J.P., Kutok J.L., Look A.T. Cre/lox-regulated transgenic zebrafish model with conditional myc-induced T cell acute lymphoblastic leukemia. Proc Natl Acad Sci USA 2005, 102(17):6068-6073.
23. Ferrando A.A., Neuberg D.S., Staunton J., Loh M.L., Huard C., Raimondi S.C., et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002, 1(1):75-87.
24. Feng H., Langenau D.M., Madge J.A., Quinkertz A., Gutierrez A., Neuberg D.S., et al. Heat-shock induction of T-cell lymphoma/leukaemia in conditional Cre/lox-regulated transgenic zebrafish. Br J Haematol 2007, 138(2):169-175.
25. Feng H., Stachura D.L., White R.M., Gutierrez A., Zhang L., Sanda T., et al. T-lymphoblastic lymphoma cells express high levels of BCL2, S1P1, and ICAM1, leading to a blockade of tumor cell intravasation. Cancer Cell 2010, 18(4):353-366.
26. Strasser A., Harris A.W., Bath M.L., Cory S. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 1990, 348(6299):331-333.
27. Kelly P.N., Strasser A. The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy. Cell Death Differ 2011, 18(9):1414-1424.
28. Smith A.C., Raimondi A.R., Salthouse C.D., Ignatius M.S., Blackburn J.S., Mizgirev I.V., et al. High-throughput cell transplantation establishes that tumor-initiating cells are abundant in zebrafish T-cell acute lymphoblastic leukemia. Blood 2010, 115(16):3296-3303.
29. Gutierrez A., Grebliunaite R., Feng H., Kozakewich E., Zhu S., Guo F., et al. Pten mediates myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia. J Exp Med 2011, 208(8):1595-1603.
30. Sandy A.R., Jones M., Maillard I. Notch signaling and development of the hematopoietic system. Adv Exp Med Biol 2012, 727:71-88.
31. Chen J., Jette C., Kanki J.P., Aster J.C., Look A.T., Griffin J.D. NOTCH1-induced T-cell leukemia in transgenic zebrafish. Leukemia 2007, 21(3):462-471.
32. Frazer J.K., Meeker N.D., Rudner L., Bradley D.F., Smith A.C., Demarest B., et al. Heritable T-cell malignancy models established in a zebrafish phenotypic screen. Leukemia 2009, 23(10):1825-1835.
33. Rudner L.A., Brown K.H., Dobrinski K.P., Bradley D.F., Garcia M.I., Smith A.C., et al. Shared acquired genomic changes in zebrafish and human T-ALL. Oncogene 2011, 30(41):4289-4296.
34. Sabaawy H.E., Azuma M., Embree L.J., Tsai H.J., Starost M.F., Hickstein D.D. TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia. Proc Natl Acad Sci USA 2006, 103(41):15166-15171.
35. van der Weyden L., Giotopoulos G., Rust A.G., Matheson L.S., van Delft F.W., Kong J., et al. Modeling the evolution of ETV6-RUNX1-induced B-cell precursor acute lymphoblastic leukemia in mice. Blood 2011, 118(4):1041-1051.
36. Zhuravleva J., Paggetti J., Martin L., Hammann A., Solary E., Bastie J.N., et al. MOZ/TIF2-induced acute myeloid leukaemia in transgenic fish. Br J Haematol 2008, 143(3):378-382.
37. Deguchi K., Ayton P.M., Carapeti M., Kutok J.L., Snyder C.S., Williams I.R., et al. MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP. Cancer Cell 2003, 3(3):259-271.
38. Kalev-Zylinska M.L., Horsfield J.A., Flores M.V., Postlethwait J.H., Vitas M.R., Baas A.M., et al. Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis. Development 2002, 129(8):2015-2030.
39. Yeh J.R., Munson K.M., Elagib K.E., Goldfarb A.N., Sweetser D.A., Peterson R.T. Discovering chemical modifiers of oncogene-regulated hematopoietic differentiation. Nat Chem Biol 2009, 5(4):236-243.
40. Dayyani F., Wang J., Yeh J.R., Ahn E.Y., Tobey E., Zhang D.E., et al. Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival. Blood 2008, 111(8):4338-4347.
41. McCormack E., Bruserud O., Gjertsen B.T. Genetic models of acute myeloid leukaemia. Oncogene 2008, 27(27):3765-3779.
42. Yuan Y., Zhou L., Miyamoto T., Iwasaki H., Harakawa N., Hetherington C.J., et al. AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations. Proc Natl Acad Sci USA 2001, 98(18):10398-10403.
43. Yan M., Burel S.A., Peterson L.F., Kanbe E., Iwasaki H., Boyapati A., et al. Deletion of an AML1-ETO C-terminal NcoR/SMRT-interacting region strongly induces leukemia development. Proc Natl Acad Sci USA 2004, 101(49):17186-17191.
44. Onnebo S.M., Condron M.M., McPhee D.O., Lieschke G.J., Ward A.C. Hematopoietic perturbation in zebrafish expressing a tel-jak2a fusion. Exp Hematol 2005, 33(2):182-188.
45. Valentino L., Pierre J. JAK/STAT signal transduction: regulators and implication in hematological malignancies. Biochem Pharmacol 2006, 71(6):713-721.
46. Schwaller J., Frantsve J., Aster J., Williams I.R., Tomasson M.H., Ross T.S., et al. Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes. EMBO J 1998, 17(18):5321-5333.
47. Carron C., Cormier F., Janin A., Lacronique V., Giovannini M., Daniel M.T., et al. TEL-JAK2 transgenic mice develop T-cell leukemia. Blood 2000, 95(12):3891-3899.
48. dos Santos N.R., Ghysdael J. A transgenic mouse model for TEL-JAK2-induced B-cell lymphoma/leukemia. Leukemia 2006, 20(1):182-185.
49. Forrester A.M., Grabher C., McBride E.R., Boyd E.R., Vigerstad M.H., Edgar A., et al. NUP98-HOXA9-transgenic zebrafish develop a myeloproliferative neoplasm and provide new insight into mechanisms of myeloid leukaemogenesis. Br J Haematol 2011, 155(2):167-181.
50. Kroon E., Thorsteinsdottir U., Mayotte N., Nakamura T., Sauvageau G. NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice. EMBO J 2001, 20(3):350-361.
51. Iwasaki M., Kuwata T., Yamazaki Y., Jenkins N.A., Copeland N.G., Osato M., et al. Identification of cooperative genes for NUP98-HOXA9 in myeloid leukemogenesis using a mouse model. Blood 2005, 105(2):784-793.
52. Grisendi S., Mecucci C., Falini B., Pandolfi P.P. Nucleophosmin and cancer. Nat Rev Cancer 2006, 6(7):493-505.
53. Bolli N., Payne E.M., Grabher C., Lee J.S., Johnston A.B., Falini B., et al. Expression of the cytoplasmic NPM1 mutant (NPMc+) causes the expansion of hematopoietic cells in zebrafish. Blood 2010, 115(16):3329-3340.
54. Harris T.J., McCormick F. The molecular pathology of cancer. Nat Rev Clin Oncol 2010, 7(5):251-265.
55. Le X., Langenau D.M., Keefe M.D., Kutok J.L., Neuberg D.S., Zon L.I. Heat shock-inducible Cre/Lox approaches to induce diverse types of tumors and hyperplasia in transgenic zebrafish. Proc Natl Acad Sci USA 2007, 104(22):9410-9415.
56. Hayakawa F., Towatari M., Iida H., Wakao H., Kiyoi H., Naoe T., et al. Differential constitutive activation between STAT-related proteins and MAP kinase in primary acute myelogenous leukaemia. Br J Haematol 1998, 101(3):521-528.
57. Lewis R.S., Stephenson S.E., Ward A.C. Constitutive activation of zebrafish Stat5 expands hematopoietic cell populations in vivo. Exp Hematol 2006, 34(2):179-187.
58. Taylor A.M., Zon L.I. Zebrafish tumor assays: the state of transplantation. Zebrafish 2009, 6(4):339-346.
59. Liu S., Leach S.D. Zebrafish models for cancer. Annu Rev Pathol 2011, 6:71-93.
60. Mizgirev I.V., Revskoy S. A new zebrafish model for experimental leukemia therapy. Cancer Biol Ther 2010, 9(11):895-902.
61. Corkery D.P., Dellaire G., Berman J.N. Leukaemia xenotransplantation in zebrafish - chemotherapy response assay in vivo. Br J Haematol 2011, 153(6):786-789.
62. Pruvot B., Jacquel A., Droin N., Auberger P., Bouscary D., Tamburini J., et al. Leukemic cell xenograft in zebrafish embryo for investigating drug efficacy. Haematologica 2011, 96(4):612-616.
63. Traver D., Paw B.H., Poss K.D., Penberthy W.T., Lin S., Zon L.I. Transplantation and in vivo imaging of multilineage engraftment in zebrafish bloodless mutants. Nature Immunol 2003, 4(12):1238-1246.
64. Traver D., Winzeler A., Stern H.M., Mayhall E.A., Langenau D.M., Kutok J.L., et al. Effects of lethal irradiation in zebrafish and rescue by hematopoietic cell transplantation. Blood 2004, 104(5):1298-1305.
65. de Jong J.L., Burns C.E., Chen A.T., Pugach E., Mayhall E.A., Smith A.C., et al. Characterization of immune-matched hematopoietic transplantation in zebrafish. Blood 2011, 117(16):4234-4242.
66. Oettinger M.A., Schatz D.G., Gorka C., Baltimore D. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 1990, 248(4962):1517-1523.
67. Wang L., Gural A., Sun X.J., Zhao X., Perna F., Huang G., et al. The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation. Science 2011, 333(6043):765-769.
68. Clark K.J., Voytas D.F., Ekker S.C. A TALE of two nucleases: gene targeting for the masses?. Zebrafish 2011, 8(3):147-149.
69. Armstrong S.A., Look A.T. Molecular genetics of acute lymphoblastic leukemia. J Clin Oncol 2005, 23(26):6306-6315.
70. Marcucci G., Haferlach T., Döhner H. Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications. J Clin Oncol 2011, 29(5):475-486.
71. Szczepański T., Harrison C.J., van Dongen J.J. Genetic aberrations in paediatric acute leukaemias and implications for management of patients. Lancet Oncol 2010, 11(9):880-889.